Archive
PZ Cussons among few features on a summery Tuesday
The agenda for Tuesday is distinctly summery, albeit PZ Cussons is among a few features in the books.
Company
LON:PRM
Proteome Sciences plc is a Leader in Applied Proteomics and Peptidomics We deliver content for Precision Medicine through services, biomarkers and reagents. We use high sensitivity proprietary technologies to detect biomarkers across major human diseases in areas of significant unmet need where biomarkers have the potential to transform disease management and treatment for the first time at the level of the individual. Our proteomics expertise provides complementary and enabling content and insight for our strategic partners to develop more effective, time and cost-efficient healthcare solutions.
35 stories · page 2 of 2
Archive
The agenda for Tuesday is distinctly summery, albeit PZ Cussons is among a few features in the books.
Archive
The portfolio could do with a bit of hysteria over the Gatwick Gusher to perk up its performance
Archive
It's all down to the astonishing rise of mySquar (with a nod of acknowledgement to Bilby, too)
Sirius Minerals concluded a fundraising, while Sound made a significant gas find
Shares in explorer Amur Minerals soared on Monday after it announced a tie with Chinese nickel giant Jinchuan
TyraTech's share price rose this afternoon after one of its non-executive directors bought half a million shares at a 25% premium
The rise of 'precision medicine' continues to support the biomarker business with revenues from licensing, sales and services up 30% in 2015.
Investments and investor services
Proteome gave a bullish update on its pipeline situation while Central Rand Gold struggles to sell its Dutch arm.
Investments and investor services
Phorm was a big loser again today while Motive TV has added a record feature to its over-the-top television app sending shares higher.